Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Sponsor: AstraZeneca
Summary
The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).
Official title: A Phase II, Open-label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR)
Key Details
Gender
All
Age Range
18 Years - 130 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-03-12
Completion Date
2028-06-07
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
Volrustomig
Volrustomig will be administered as intravenous (IV) infusion.
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)
FOLFIRI will be administered as IV infusion.
Bevacizumab
Bevacizumab will be administered as IV infusion.
Locations (76)
Research Site
Scottsdale, Arizona, United States
Research Site
Los Angeles, California, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Chicago, Illinois, United States
Research Site
Baltimore, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Rochester, Minnesota, United States
Research Site
Trenton, New Jersey, United States
Research Site
Rochester, New York, United States
Research Site
Cleveland, Ohio, United States
Research Site
Portland, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Nashville, Tennessee, United States
Research Site
Houston, Texas, United States
Research Site
East Melbourne, Australia
Research Site
Wollongong, Australia
Research Site
Woodville South, Australia
Research Site
Victoria, British Columbia, Canada
Research Site
Barrie, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Beijing, China
Research Site
Chengdu, China
Research Site
Harbin, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Wuhan, China
Research Site
Zhengzhou, China
Research Site
Bordeaux, France
Research Site
Marseille, France
Research Site
Montpellier, France
Research Site
Montpellier, France
Research Site
Poitiers, France
Research Site
Saint-Priez En Jarez, France
Research Site
Villejuif, France
Research Site
Berlin, Germany
Research Site
Dresden, Germany
Research Site
Essen, Germany
Research Site
Hamburg, Germany
Research Site
Marburg, Germany
Research Site
Bologna, Italy
Research Site
Castelfranco Veneto, Italy
Research Site
Florence, Italy
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Naples, Italy
Research Site
Pavia, Italy
Research Site
Pisa, Italy
Research Site
Roma, Italy
Research Site
Amsterdam, Netherlands
Research Site
Maastricht, Netherlands
Research Site
Zwolle, Netherlands
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Yongin-si, South Korea
Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Pamplona, Spain
Research Site
Santander, Spain
Research Site
Valencia, Spain
Research Site
Kaohsiung City, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taoyuan District, Taiwan
Research Site
Yung Kang City, Taiwan
Research Site
Cambridge, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Metropolitan Borough of Wirral, United Kingdom